Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance

NCT05852730 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Motion Sickness, Space
Motion Simulation
Parabolic Flight

Interventions

DRUG: DPI-386 Nasal Gel
DRUG: Other (e.g., promethazine, meclizine)

Sponsor

Repurposed Therapeutics, Inc.

Collaborators

[object Object]